Idera Pharmaceuticals CEO Vincent Milano's 2019 pay falls 25% to $1.3M
Idera Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 6, 2020
Idera Pharmaceuticals reported fiscal year 2019 executive compensation information on April 6, 2020.
In 2019, five executives at Idera Pharmaceuticals received on average a compensation package of $857K, a 15% decrease compared to previous year.
Average pay of disclosed executives at Idera Pharmaceuticals
Vincent J. Milano, Chief Executive Officer, received $1.3M in total, which decreased by 25% compared to 2018. 45% of Milano's compensation, or $600K, was in salary. Milano also received $315K in non-equity incentive plan, $279K in option awards, $106K in stock awards, as well as $37K in other compensation.
For fiscal year 2019, the median employee pay was $278,816 at Idera Pharmaceuticals. Therefore, the ratio of Vincent J. Milano's pay to the median employee pay was 5 to one.
Jonathan Yingling, Chief Scientific Officer, received a compensation package of $812K, which decreased by 17% compared to previous year. 49% of the compensation package, or $400K, was in salary.
R. Clayton Fletcher, Senior Vice President, Business Development and Strategy, earned $798K in 2019, a 18% decrease compared to previous year.
Bryant D. Lim, General Counsel, received $732K in 2019, which decreases by 6% compared to 2018.
John J. Kirby, Chief Financial Officer, earned $606K in 2019, a 9% increase compared to previous year.
Related executives
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
John Kirby
Idera Pharmaceuticals
Chief Financial Officer
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
Bryant Lim
Idera Pharmaceuticals
General Counsel
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
You may also like
Source: SEC filing on April 6, 2020.